Capital Analysts LLC Portfolio holdings
Capital Analysts is a Lincoln Investment company that provides a ready-made wealth management platform to independent financial professionals who serve affluent clients. Capital Analysts dates from 2012 and belongs to Lincoln Investment Capital Holdings; Lincoln Investment Planning, a brokerage and advisory firm under the same ownership, handles brokerage services for it and its advisors. Those advisors work across the United States as independent contractors, not employees. Their clients include individuals, high net worth individuals, trusts, foundations, businesses and charities, and Capital Analysts also offers its institutional advisory services to other advisers and trust companies. The portfolios it builds aim to be diversified and rest on asset allocation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$24.6M |
| 2 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$16.4M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$16.1M |
| 4 |
iShares Systematic Alternatives Active ETF
IALT
|
+$16M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$7.72M |
| 2 |
Citigroup
C
|
+$7.28M |
| 3 |
iShares Gold Trust
IAU
|
+$6.25M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.23M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.75% |
| 2 | Technology | 5.6% |
| 3 | Financials | 4.52% |
| 4 | Industrials | 2.67% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1376
Curbline Properties
CURB
$3.6B
| $6K | ﹤0.01% |
202
-54
| -21% | -$1.54K |
2025 Q1
5 quarters
|
|
1377
Agilent Technologies
A
$50.5B
| $5K | ﹤0.01% |
34
| – | – |
2025 Q4
2 quarters
|
|
1378
Achieve Life Sciences
ACHV
$677M
| $5K | ﹤0.01% |
700
| – | – |
2025 Q3
3 quarters
|
|
1379
iShares Agency Bond ETF
AGZ
$662M
| $5K | ﹤0.01% |
+45
| New | +$4.92K |
2026 Q2
0 quarters
|
|
1380
Atlanta Braves Holdings Series A
BATRA
$3.58B
| $5K | ﹤0.01% |
94
| – | – |
2024 Q4
6 quarters
|
|
1381
Brookfield Renewable
BEP
$9.45B
| $5K | ﹤0.01% |
139
| – | – |
2021 Q1
21 quarters
|
|
1382
Dutch Bros
BROS
$4.97B
| $5K | ﹤0.01% |
72
| – | – |
2025 Q1
5 quarters
|
|
1383
Brixmor Property Group
BRX
$9.28B
| $5K | ﹤0.01% |
154
-88
| -36% | -$2.69K |
2025 Q1
5 quarters
|
|
1384
Conagra Brands
CAG
$7.26B
| $5K | ﹤0.01% |
377
| – | – |
2025 Q4
2 quarters
|
|
1385
DoubleLine Opportunistic Bond ETF
DBND
$833M
| $5K | ﹤0.01% |
109
-55
| -34% | -$2.51K |
2022 Q4
14 quarters
|
|
1386
DexCom
DXCM
$29.8B
| $5K | ﹤0.01% |
68
| – | – |
2021 Q1
21 quarters
|
|
1387
EVgo
EVGO
$264M
| $5K | ﹤0.01% |
2,794
| – | – |
2023 Q3
11 quarters
|
|
1388
Fiserv Inc
FISV
$33.8B
| $5K | ﹤0.01% |
90
-92
| -51% | -$5.14K |
2020 Q3
23 quarters
|
|
1389
Franklin FTSE Japan ETF
FLJP
$4.16B
| $5K | ﹤0.01% |
121
| – | – |
2024 Q4
6 quarters
|
|
1390
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.23B
| $5K | ﹤0.01% |
167
| – | – |
2025 Q1
5 quarters
|
|
1391
First Trust Nasdaq Bank ETF
FTXO
$242M
| $5K | ﹤0.01% |
116
| – | – |
2025 Q3
3 quarters
|
|
1392
W.W. Grainger
GWW
$68.3B
| $5K | ﹤0.01% |
4
| – | – |
2023 Q1
13 quarters
|
|
1393
HP
HPQ
$26.1B
| $5K | ﹤0.01% |
212
-51
| -19% | -$1.13K |
2024 Q2
8 quarters
|
|
1394
IQVIA
IQV
$45.8B
| $5K | ﹤0.01% |
25
-10
| -29% | -$1.74K |
2024 Q3
7 quarters
|
|
1395
iShares US Healthcare ETF
IYH
$4.79B
| $5K | ﹤0.01% |
77
| – | – |
2026 Q1
1 quarter
|
|
1396
Magna International
MGA
$16.2B
| $5K | ﹤0.01% |
74
-38
| -34% | -$2.38K |
2024 Q2
8 quarters
|
|
1397
Martin Marietta Materials
MLM
$37.6B
| $5K | ﹤0.01% |
8
| – | – |
2024 Q3
7 quarters
|
|
1398
Murphy Oil
MUR
$5.04B
| $5K | ﹤0.01% |
144
-268
| -65% | -$10.3K |
2025 Q3
3 quarters
|
|
1399
NNN REIT
NNN
$8.05B
| $5K | ﹤0.01% |
100
| – | – |
2025 Q1
5 quarters
|
|
1400
Novo Nordisk
NVO
$181B
| $5K | ﹤0.01% |
100
-17
| -15% | -$730 |
2023 Q3
11 quarters
|
|
Similar funds
Capital Analysts LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Capital Analysts LLC held 1,612 positions worth $4.34B, up 14% from $3.81B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Analysts LLC deployed $223M of net new capital in Q2 2026, opening 75 new positions and adding to 544 existing holdings. Its largest new stake was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $7.72M trimmed.
- Capital Analysts LLC's largest Q2 2026 buy was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $24.6M increase.
- Capital Analysts LLC's biggest Q2 2026 reduction was Zoetis, cutting an estimated $7.72M.
- Capital Analysts LLC fully exited Hershey in Q2 2026, selling an estimated $113K.
- Capital Analysts LLC's ten largest holdings make up 30% of its $4.34B portfolio in Q2 2026.
- Capital Analysts LLC opened 75 new positions and closed 76 in Q2 2026.
- Capital Analysts LLC's portfolio value rose 14% quarter-over-quarter to $4.34B.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.